Published on
May 30, 2025
Promising Treatment To Raise the Standard of Care in Lower-Risk MDS-Related Anemia
This article is sponsored by Bristol Myers Squibb. Dr. Shah was compensated by BMS for his participation. Myelodysplastic syndromes (MDS) are a group of hematologic malignancies in which a person’s bone marrow doesn’t produce enough healthy red blood cells …
Source:
Cancer Network - New Jersey
-
Pending
